Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Gorilla is a vertically integrated wellness company that specializes in the development and marketing of organic hemp-derived cannabidiol (CBD) products. Established in 2013, the company is recognized for its commitment to sustainable, non-GMO, and organic farming practices. Their product portfolio includes CBD oils, topicals, capsules, and pet wellness products, all formulated to support general health and specific conditions like pain and anxiety. A key differentiator for the brand is its proprietary GG BioEnhanced Complex, which is designed to increase the bioavailability and absorption of cannabinoids. Green Gorilla serves a global market through both direct-to-consumer e-commerce and retail partnerships. The company remains a prominent player in the botanical health space, focusing on high-purity, third-party tested hemp supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Gorilla.